Abstract
The advent of new oral anticoagulants (NOACs) is transforming the care of patients in need of anticoagulant therapy. NOACs offer the opportunity to provide patients with more effective, safer and more convenient anticoagulant therapy but there are still pitfalls and hurdles.
MeSH terms
-
Anticoagulants* / classification
-
Anticoagulants* / pharmacology
-
Chemoprevention / methods
-
Chemoprevention / trends*
-
Clinical Trials as Topic
-
Dose-Response Relationship, Drug
-
Humans
-
Patient-Centered Care
-
Therapeutic Equivalency
-
Thromboembolism / prevention & control*